The struggle for male hormonal contraception

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 25, Issue 2, 2011, Pages 369-375

  Nieschlag, Eberhard ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

DMPA; etonogestrel, Weimar Manifesto; gestagens; norethisterone; pregnancy rates; sperm counts; testosterone

Indexed keywords

ETONOGESTREL; FOLLITROPIN; GESTAGEN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; MALE CONTRACEPTIVE AGENT; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ENANTATE; TESTOSTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE;

CLINICAL TRIAL (TOPIC); DRUG INDUSTRY; HEALTH PROGRAM; HORMONAL CONTRACEPTION; HORMONE SUBSTITUTION; HUMAN; MALE FERTILITY; PREGNANCY RATE; REVIEW;

AZOOSPERMIA; CLINICAL TRIALS AS TOPIC; CONTRACEPTION; CONTRACEPTIVE AGENTS, MALE; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MALE; MEDROXYPROGESTERONE ACETATE; NORETHINDRONE; PREGNANCY; PREGNANCY RATE; PROGESTERONE CONGENERS; PROGESTINS; TESTOSTERONE;

EID: 79952568649     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2010.08.008     Document Type: Review

References (33)

1. Nieschlag E & Behre HM (eds.). Testosterone: action, deficiency, substitution. 2nd ed. Heidelberg: Springer, 1998, p. 514.
2. Nieschlag E. Clinical trials in male hormonal contraception. Contraception, in press.
3. Nieschlag E. 10th Summit Meeting group. 10th Summit Meeting: recommendations for regulatory approval for hormonal male contraception. Contraception 2007; 75: 166-167.
4. McLachlan R, O'Donnell L, Stanton PG et al. Effects of testosterone enanthate plus medroxy-progesterone acetate on semen quality, reproductive hormones and germ cell populations in normal young men. Journal of Clinical Endocrinology & Metabolism 2002; 87: 546-556. (Pubitemid 34158217)
5. Grimes DA, Lopez LM, Gallo MF et al. Steroid hormones for contraception in men (review). Cochrane Database of Systematic Reviews 2007. 004316.
6. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 1990; 336: 955-959.
7. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertility and Sterility 1996; 65: 821-829.
8. Waites GMH. Development of methods of male contraception: impact of the World Health Organization Task Force. Fertility and Sterility 2003; 80: 1-15.
9. Behre HM, Baus S, Kliesch S et al. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders. Journal of Clinical Endocrinology & Metabolism 1995; 80: 2394-2403.
10. Nieschlag E. Testosterone treatment comes of age: new options for hypogonadal men. Clinical Endocrinology 2006; 65: 275-281.
11. Gu Y-Q,Wang X-H, Xu D et al. A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men. Journal of Clinical Endocrinology & Metabolism 2003; 88: 562-568. (Pubitemid 36207791)
12. Gu Y, Liang X, Wu Wet al. Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. Journal of Clinical Endocrinology & Metabolism 2009; 94: 1910-1915.
13. Zhang L, Shal IH, Liu Y et al. The acceptability of an injectable, once-a-month male contraceptive in China. Contraception 2006; 73: 548-553.
14. Barfield A, Melo J, Coutinho E et al. Pregnancies associated with sperm concentrations below 10 millionion/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters. Contraception 1979; 20: 121-127. (Pubitemid 9245244)
15. Knuth UA, Yeung CH & Nieschlag E. Combination of 19-nortestosterone- hexyoxyphenylpropionate (Anadur) and depotmedroxyprogesterone-acetate (Clinovir) for male contraception. Fertility and Sterility 1989; 51: 1011-1018. (Pubitemid 19156907)
16. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Comparison of two androgens plus depot-medroxyprogesterone acetate for suppression to azoospermia in Indonesian men. Fertility and Sterility 1993; 60: 1062-1068.
17. Turner L, Conway AJ, Jiminez M et al. Contraceptive efficacy of a depot gestagen and androgen combination in men. Journal of Clinical Endocrinology & Metabolism 2003; 88: 4659-4667. (Pubitemid 37357508)
18. Djerassi C. The mother of the pill. Recent Progress Hormone Research 1995; 50: 1-17.
19. Kamischke A, Venherm S, Plöger D et al. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception. Journal of Clinical Endocrinology & Metabolism 2001; 86: 303-309. (Pubitemid 32109810)
20. Meriggiola MC, Costantino A, Saad F et al. Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate. Journal of Clinical Endocrinology & Metabolism 2005; 90: 2005-2014. (Pubitemid 40586232)
21. Kamischke A, Heuermann T, Krüger K et al. An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations. Journal of Clinical Endocrinology & Metabolism 2002; 87: 530-539. (Pubitemid 34158215)
22. WHO. Controlled trials register NET-EN plus TU as a male contraceptive (WHO-HRP ID A25165), http://www.who.int/reproductive-health/rhl/a25165.html; 2005 [accessed 29.11.05].
23. Nieschlag E. Male hormonal contraception: love's labour's lost? Journal of Clinical Endocrinology & Metabolism 2009; 94: 1910-1915.
24. Wu FCW, Balasubramanian R, Mulders TMT et al. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism. Journal of Clinical Endocrinology & Metabolism 1999; 84: 112-122. (Pubitemid 29036688)
25. Kinniburgh D, Anderson RA & Baird DT. Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride. Journal of Andrology 2001; 22: 88-95. (Pubitemid 32013949)
26. Brady BM, Walton M, Hollow N et al. Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception. Human Reproduction 2004; 19: 2658-2667. (Pubitemid 39481297)
27. Mommers E, Kersemaeker WM, Elliesen J et al. Male hormonal contraception: a double-blind, placebo-controlled study. Journal of Clinical Endocrinology & Metabolism 2008; 93: 2572-2580. (Pubitemid 352008522)
28. Liu PY, Swerdloff RS, Christenson PD et al. Rate, extent and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet 2006; 367: 1412-1420.
29. Liu PY, Swerdloff RS, Anawalt BD et al. Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis. Journal of Clinical Endocrinology & Metabolism 2008; 93: 1774-1783. (Pubitemid 351656517)
30. Darroch JE. Male fertility control - where are the men? Contraception 2008 August 22; 78(4 Suppl.): S7-S17 (Epub).
31. Cooper TG & Yeung C- H. Pharmacological approach to male contraception. In Nieschlag E, Behre HM & Nieschlag S (eds.). Andrology - male reproductive health and dysfunction. 3rd ed. Heidelberg: Springer, 2010, pp. 589-599.
32. Page ST, Amory JK & Bremner WJ. Advances in male contraception. Endocrine Reviews 2008; 29: 465-493. (Pubitemid 351831509)
33. Barfield JP, Nieschlag E & Cooper TG. Fertility control in wildlife: man as model. Contraception 2006; 73: 6-22. (Pubitemid 41818859)